Find a Clinical Trial
Is a clinical trial right for you? Search our database to find studies for which you may be eligible.
Randomized Phase II Trial Evaluation the Addition of the IGF-1R Monoclonal Antibody Receptor Ganitumab to Multiagent Chemotherapy for Patients with Newly Diagnosed Metastatic Ewing Sarcoma
Study Type: Treatment
Phase: II
NCTID: NCT02306161
Principal Investigator:
A Pilot Study Evaluating the Use of mTor Inhibitor Sirolimus in Children and Young Adults With Desmoid-Type Fibromatosis
Study Type: Treatment
Phase: Feasibility/Pilot
NCTID: NCT01265030
Principal Investigator:
Brightline-4: A Phase III open-label, single-arm, multi-center study to assess the safety and efficacy of brigimadlin BI 907828 treatment in patients with treatment-na�ve or pre-treated advanced dedifferentiated liposarcoma
Study Type: Treatment
Phase: III
NCTID: NCT06058793
Principal Investigator:
Benjamin Powers
A Randomized Phase 3 Study of Vincristine, Dactinomycin, Cyclophosphamide VAC Alternating with Vincristine and Irinotecan VI versus VAC/VI plus Temsirolimus TORI, Torisel, NSC 683864 in Patients with Intermediate Risk IR Rhabdomyosarcoma RMS
Study Type: Treatment
Phase: III
NCTID: NCT02567435
Principal Investigator:
Keith August
A Phase III, Multicentre, Randomised, Double-Blind Study to Assess the Safety and Efficacy of Emactuzumab vs. Placebo in Subjects with Tenosynovial Giant Cell Tumour
Study Type: Treatment
Phase: III
NCTID: NCT05417789
Principal Investigator:
Benjamin Powers
Pazopanib Neoadjuvant Trial in Non-Rhabdomyosarcoma Soft Tissue Sarcomas PAZNTIS: A Phase II/III Randomized Trial of Preoperative Chemoradiation or Preoperative Radiation Plus or Minues Pazopanib NSC 737754, IND 118613
Study Type: Treatment
Phase: II/III
NCTID: NCT02180867
Principal Investigator:
A Randomized Phase III Study of Neoadjuvant Chemotherapy followed by Surgery versus Surgery Alone for Patients with High Risk Retroperitoneal Sarcoma STRASS2
Study Type: Treatment
Phase: III
NCTID: NCT04031677
Principal Investigator:
Luke Selby
A Prospective Phase III Study of Patients with Newly Diagnosed Very Low-risk and Low-risk Fusion Negative Rhabdomyosarcoma
Study Type: Treatment
Phase: III
NCTID: NCT05304585
Principal Investigator:
Keith August
A Phase 2 Study of DS-8201a NSC 807708 in Adolescents, or Young Adults with Recurrent HER2+ Osteosarcoma
Study Type: Treatment
Phase: II
NCTID: NCT04616560
Principal Investigator:
Kevin Ginn
Biospecimen Analysis in Determining Effects of Chemotherapy on Fertility in Osteosarcoma Survivors
Study Type: Other
Phase: N/A
NCTID: NCT03206450
Principal Investigator:
Keith August